Status report
Get it in writing
The official USPTO status record for BRIM BIOTECHNOLOGY, serial 90304391, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
BRIM BIOTECHNOLOGYSerial 90304391 · Principal Register
Live · Registered
Owner: BRIM BIOTECHNOLOGY, INC.
Class 005 - Pharmaceuticals
Filed Nov 06, 2020
Registered Oct 12, 2021
The record shows that “BRIM BIOTECHNOLOGY” is a live, registered mark on the Principal Register, owned by BRIM BIOTECHNOLOGY, INC., a corporation organized in Taiwan. The mark covers a broad range of pharmaceutical goods, including external medicines, injections for muscle regeneration, corneal and wound healing, osteoarthritis treatments, antibiotics, vaccines for humans and animals, diagnostic preparations, medical dressings, and related dermatological and ophthalmic products. A similar name would raise the closest concern in the same pharmaceutical and medical product categories, especially those involving injections, vaccines, and diagnostic preparations. The record does not grant control over every use of the word “biotechnology” outside these specific goods. The prosecution history shows a final refusal in May 2021, followed by registration in October 2021, indicating the mark was ultimately accepted on the Principal Register. The latest event is the registration date, Oct 12 2021, with no subsequent enforcement actions recorded. For someone considering a similar name, the presence of this active, broad‑scope pharmaceutical registration suggests a meaningful risk of conflict in related medical product markets.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.